Determination of Optimal Sleep Treatment Elements - Pilot
DOSE
1 other identifier
interventional
169
1 country
1
Brief Summary
Previous research has shown the efficacy of (combinations of) individual components of cognitive behavioral therapy for insomnia (CBT-I), namely sleep hygiene education, sleep optimization, stimulus control therapy, deactivation/relaxation training, and cognitive therapy. However, their relative effects, i.e., their effects in direct comparison with each other, are yet to be assessed. In this pilot study, a smartphone and web application developed to treat insomnia using these treatment components will be tested. Two future studies will investigate the components' relative efficacy in order to identify the most effective component or combination of components for digitized treatment of chronic insomnia by means of the Multiphase Optimization Strategy (MOST), and verify this intervention's effect in a randomized controlled trial (RCT).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 6, 2022
CompletedFirst Submitted
Initial submission to the registry
September 28, 2022
CompletedFirst Posted
Study publicly available on registry
September 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 3, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 3, 2022
CompletedSeptember 14, 2023
September 1, 2022
3 months
September 28, 2022
September 13, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Insomnia severity post-intervention
Assessed with the Insomnia Severity Index (ISI), with scores ranging from 0 to 28, where higher scores indicate higher insomnia severity, and a score equal to or above 10 indicates clinical significance.
11 weeks after study entry (randomization)
Secondary Outcomes (10)
Sleep diary assessed sleep efficiency (SE) at end of intervention
Approximately 10 weeks after study entry (randomization)
Sleep diary assessed sleep onset latency (SOL) at end of intervention
Approximately 10 weeks after study entry (randomization)
Sleep diary assessed wake after sleep onset (WASO) at end of intervention
Approximately 10 weeks after study entry (randomization)
Sleep diary assessed nocturnal awakenings (NA) at end of intervention
Approximately 10 weeks after study entry (randomization)
Sleep diary assessed total sleep time (TST) at end of intervention
Approximately 10 weeks after study entry (randomization)
- +5 more secondary outcomes
Study Arms (2)
Intervention
EXPERIMENTALAdministration of sleep hygiene, sleep optimization, stimulus control therapy, deactivation/relaxation training, and cognitive therapy.
Control
NO INTERVENTIONWaitlist control (sleep diary only); access to treatment after final measurement
Interventions
Automated digital administration of sleep hygiene, sleep optimization, stimulus control therapy, deactivation/relaxation training, and cognitive therapy modules via mobile or web application, lasting approximately six weeks.
Eligibility Criteria
You may qualify if:
- Adults (≥18 years)
- Individuals who report moderate-to-severe insomnia symptoms (a score ≥10 on the Insomnia Severity Index, ISI)
- Individuals with access to a smartphone or computer with internet connection
- Individuals who report sufficient technological proficiency (e.g., ability to download apps)
You may not qualify if:
- Children (\<18 years)
- Individuals who report mild or no clinically relevant insomnia symptoms (a score \<10 on the ISI)
- Individuals who have a shift-work schedule or are on maternity/paternity leave, if this impacts their sleep quality or amount of sleep
- Individuals who are unable to read Danish
- Individuals who report severe physical or psychological comorbidity with known effects on sleep (e.g., psychosis, cardiovascular disease, cancer, COPD)
- Individuals who report other diagnosed sleep or circadian rhythm disorders (e.g., sleep apnea, narcolepsy)
- Individuals who have previously used the "Hvil®"-app, e.g., during the beta test phase
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Aarhuslead
- TrygFonden, Denmarkcollaborator
- Enversion A/Scollaborator
Study Sites (1)
Aarhus University
Aarhus, Central Jutland, 8000, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Zachariae, DMSc, MSc
Aarhus University, Aarhus University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 28, 2022
First Posted
September 30, 2022
Study Start
September 6, 2022
Primary Completion
December 3, 2022
Study Completion
December 3, 2022
Last Updated
September 14, 2023
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- No later than six months after publication, no end date.
- Access Criteria
- Data will be shared exclusively with other researchers and for research purposes only. Researchers requesting the data will have to provide a methodologically sound research proposal clarifying how the data will be used and for what purpose.
All individual participant data collected during the study will be made available in an irreversibly anonymized form. However, only data of those participants can be shared who have explicitly given consent to this as part of their informed consent to study participation. This means that it may not be possible to share all data underlying a certain publication. Data will be shared exclusively for research purposes.